The HLA-DR4-DQ8 phenotype of the recipient is associated with increased mortality after kidney transplantation

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

The HLA-DR4-DQ8 phenotype of the recipient is associated with increased mortality after kidney transplantation. / Lund, Kit P.; Eriksson, Frank; Hauge, Anne W.; Mora-Jensen, Helena I.; Sørensen, Søren S.; Bruunsgaard, Helle.

In: Clinical Immunology, Vol. 226, 108711, 2021.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Lund, KP, Eriksson, F, Hauge, AW, Mora-Jensen, HI, Sørensen, SS & Bruunsgaard, H 2021, 'The HLA-DR4-DQ8 phenotype of the recipient is associated with increased mortality after kidney transplantation', Clinical Immunology, vol. 226, 108711. https://doi.org/10.1016/j.clim.2021.108711

APA

Lund, K. P., Eriksson, F., Hauge, A. W., Mora-Jensen, H. I., Sørensen, S. S., & Bruunsgaard, H. (2021). The HLA-DR4-DQ8 phenotype of the recipient is associated with increased mortality after kidney transplantation. Clinical Immunology, 226, [108711]. https://doi.org/10.1016/j.clim.2021.108711

Vancouver

Lund KP, Eriksson F, Hauge AW, Mora-Jensen HI, Sørensen SS, Bruunsgaard H. The HLA-DR4-DQ8 phenotype of the recipient is associated with increased mortality after kidney transplantation. Clinical Immunology. 2021;226. 108711. https://doi.org/10.1016/j.clim.2021.108711

Author

Lund, Kit P. ; Eriksson, Frank ; Hauge, Anne W. ; Mora-Jensen, Helena I. ; Sørensen, Søren S. ; Bruunsgaard, Helle. / The HLA-DR4-DQ8 phenotype of the recipient is associated with increased mortality after kidney transplantation. In: Clinical Immunology. 2021 ; Vol. 226.

Bibtex

@article{7bf9a0623a72417b9231a76ce4a15f79,
title = "The HLA-DR4-DQ8 phenotype of the recipient is associated with increased mortality after kidney transplantation",
abstract = "The importance of the human leukocyte antigen (HLA) system in kidney transplantation is well-known, but it remains unexplored if patient HLA antigens constitute independent risk factors in complications after transplantation. We hypothesized that specific HLA class II phenotypes associated with immune-mediated disease (HLA-IMD) predispose to immunological activity and/or complications after kidney transplantation. Based on the literature we defined HLA-DR2-DQ6; -DR3-DQ2 and -DR4-DQ8 as HLA-IMD phenotypes. We investigated associations between HLA-IMD phenotypes in patients, biomarkers of systemic chronic inflammation at the time of transplantation, and the outcome after kidney transplantation in a retrospective cohort study of 611 kidney transplanted patients. The HLA-IMD phenotypes were associated with higher levels of biomarkers of systemic inflammation. The HLA-DR4-DQ8 phenotype was associated with mortality after transplantation in Cox analyses with adjustments for confounders. Data support the hypothesis that specific HLA class II phenotypes affects immunological pathways that determine the midterm clinical outcome of kidney transplantation.",
keywords = "HLA, Inflammation, Kidney transplantation, Mortality",
author = "Lund, {Kit P.} and Frank Eriksson and Hauge, {Anne W.} and Mora-Jensen, {Helena I.} and S{\o}rensen, {S{\o}ren S.} and Helle Bruunsgaard",
year = "2021",
doi = "10.1016/j.clim.2021.108711",
language = "English",
volume = "226",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press",

}

RIS

TY - JOUR

T1 - The HLA-DR4-DQ8 phenotype of the recipient is associated with increased mortality after kidney transplantation

AU - Lund, Kit P.

AU - Eriksson, Frank

AU - Hauge, Anne W.

AU - Mora-Jensen, Helena I.

AU - Sørensen, Søren S.

AU - Bruunsgaard, Helle

PY - 2021

Y1 - 2021

N2 - The importance of the human leukocyte antigen (HLA) system in kidney transplantation is well-known, but it remains unexplored if patient HLA antigens constitute independent risk factors in complications after transplantation. We hypothesized that specific HLA class II phenotypes associated with immune-mediated disease (HLA-IMD) predispose to immunological activity and/or complications after kidney transplantation. Based on the literature we defined HLA-DR2-DQ6; -DR3-DQ2 and -DR4-DQ8 as HLA-IMD phenotypes. We investigated associations between HLA-IMD phenotypes in patients, biomarkers of systemic chronic inflammation at the time of transplantation, and the outcome after kidney transplantation in a retrospective cohort study of 611 kidney transplanted patients. The HLA-IMD phenotypes were associated with higher levels of biomarkers of systemic inflammation. The HLA-DR4-DQ8 phenotype was associated with mortality after transplantation in Cox analyses with adjustments for confounders. Data support the hypothesis that specific HLA class II phenotypes affects immunological pathways that determine the midterm clinical outcome of kidney transplantation.

AB - The importance of the human leukocyte antigen (HLA) system in kidney transplantation is well-known, but it remains unexplored if patient HLA antigens constitute independent risk factors in complications after transplantation. We hypothesized that specific HLA class II phenotypes associated with immune-mediated disease (HLA-IMD) predispose to immunological activity and/or complications after kidney transplantation. Based on the literature we defined HLA-DR2-DQ6; -DR3-DQ2 and -DR4-DQ8 as HLA-IMD phenotypes. We investigated associations between HLA-IMD phenotypes in patients, biomarkers of systemic chronic inflammation at the time of transplantation, and the outcome after kidney transplantation in a retrospective cohort study of 611 kidney transplanted patients. The HLA-IMD phenotypes were associated with higher levels of biomarkers of systemic inflammation. The HLA-DR4-DQ8 phenotype was associated with mortality after transplantation in Cox analyses with adjustments for confounders. Data support the hypothesis that specific HLA class II phenotypes affects immunological pathways that determine the midterm clinical outcome of kidney transplantation.

KW - HLA

KW - Inflammation

KW - Kidney transplantation

KW - Mortality

U2 - 10.1016/j.clim.2021.108711

DO - 10.1016/j.clim.2021.108711

M3 - Journal article

C2 - 33667637

AN - SCOPUS:85102463723

VL - 226

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

M1 - 108711

ER -

ID: 259045804